
1. pathol biol (paris). 1999 may;47(5):553-9.

[ifn-tau, new interferon type antiretroviral activity].

[article french]

clayette p(1), martin m, dereuddre-bosquet n, tournay v, gras g, martal j,
dormont d.

author information: 
(1)cea, service de neurovirologie, dsv/drm, crssa, ipsc, 60-68,
fontenay-aux-roses, france.

type interferon (ifn) ifn-alpha demonstrated relative efficiency
in hiv-infected patients kaposi's sarcoma. nevertheless, clinical uses
have restricted several major side effects. ifn-tau non-cytotoxic
type ifn. present manuscript, described vitro effects towards 
hiv replication mode action. ifn-tau potent antiviral molecule
that interferes early step hiv biological cycle. moreover, induces 
il-6 synthesis macrophages, cytokine favorises antiviral
efficacy, probably amplifying induction 2', 5'oas rnase l.
altogether, results confirm interest ifn-tau adjuvant therapy 
hiv infection, particularly hiv/hcv-infected patients.


pmid: 10418039  [indexed medline]

